Concepedia

Xiaoman Li

XL

Statistics

Publications

36

Citations

2K

H-Index

26

Active since

2001

Affiliations

Nanjing University of Chinese Medicine(Current)

China Pharmaceutical University

China Meat Research Centre

Xuzhou Medical College

China Resources (China)

Xiaoman Li is an author at Nanjing University of Chinese Medicine specializing in medicine, oncology, and molecular oncology.

ORCID

Publications per year

2001–2024

36

Publications

36

MALAT1 induced migration and invasion of human breast cancer cells by competitively binding miR-1 with cdc42

Jinjiang Chou, Bingyu Wang, Tianjing Zheng et al. · Biochemical and Biophysical Research Communications · 2016 · 185 citations

, , +12

MiR-873/PD-L1 axis regulates the stemness of breast cancer cells

Lanlan Gao, Qianqian Guo, Xiaoman Li et al. · EBioMedicine · 2019 · 168 citations · Full text

, , +16

The 3′UTR of the pseudogene CYP4Z2P promotes tumor angiogenesis in breast cancer by acting as a ceRNA for CYP4Z1

Lufeng Zheng, Xiaoman Li, Yi Gu et al. · Breast Cancer Research and Treatment · 2015 · 133 citations

, , +11

STARD13-correlated ceRNA network-directed inhibition on YAP/TAZ activity suppresses stemness of breast cancer via co-regulating Hippo and Rho-GTPase/F-actin signaling

Lufeng Zheng, Chenxi Xiang, Xiaoman Li et al. · Journal of Hematology & Oncology · 2018 · 129 citations · Full text

, , +17

Investigation of the influence of mean HPMC particle size and number of polymer particles on the release of aspirin from swellable hydrophilic matrix tablets

Paul Wan Sia Heng, Lai Wah Chan, Michael G Easterbrook et al. · Journal of Controlled Release · 2001 · 124 citations

, , +15

1–5 of 36